NCT05437003Completed
A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients
A Cross-Sectional Study to Evaluate the Correlation Between Oculometric Measures and MDS-UPDRS in Patients With Idiopathic Parkinson's Disease (PD) and Evaluation of Oculometric Measures in Healthy Participants
Source: ClinicalTrials.gov · Last updated 16 Feb 2024
Brief summary (registry, in English)
This is a prospective study in a cohort of about 500 patients with Idiopathic Parkinson's disease, examined routinely in the neurological outpatient clinic. This study aims to evaluate the correlation between oculometric measures and clinical endpoints. Subjects will be evaluated following a physician examination.The evaluations will include MDS-UPDRS examination, as well as an oculometric evaluation for eye movements. In addition, 500 healthy subjects will be evaluated.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 465 (actual)
- First submitted
- 23 Jun 2022
- Start date
- 20 Aug 2022
- Primary completion date
- 15 Feb 2024
- Lead sponsor
- NeuraLight
- Diseases
- Parkinson disease
- NCT number
- NCT05437003
What you commit to
- Study type: Interventional
- Participants enrolled: 465
- From 20 Aug 2022 to the primary completion date, 15 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug or alcohol abuse
- Healthy subjects:
- Drug or alcohol abuse
Other illness
- Personal or 1st degree relative history of epilepsy
- Additional neurological diseases
- Personal or 1st degree relative history of epilepsy
- Neurological diseases
Other
- Inability to sit for 20 minutes on a chair in a calm manner
- Inability to sit for 20 minutes on a chair in a calm manner
Who the study is looking for
- Men and women with idiopathic PD (Hoehn \& Yahr scale 1-5)
- Age between 18 and 85 years old
- Normal or corrected vision
- Ability to follow instructions
- Willing and able to sign an informed consent form
- Age between 18 and 85 years old
- Normal or corrected vision
- Ability to follow instructions
- Willing and able to sign an informed consent form
Criteria the registry did not label
- PD patients:
Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rabin Medical Center Coordinator of this site? Confirm its status | Petah Tikva | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.